Siokas Grigorios 4

What Happened
Grigorios Siokas, CEO of Cosmos Health, acquired 388,532 shares on February 12, 2026. The Form 4 reports the transaction as a purchase for a total of $145,000 (reported price $0.37/share). A footnote clarifies these are "Exchange Shares" issued under a Debt Exchange Agreement at an exchange rate of $0.3732 per share in settlement of $145,000 of debt the company owed to Mr. Siokas. This was an acquisition (insider purchase via debt conversion), not a sale.

Key Details

• Transaction date: February 12, 2026; Form 4 filed February 13, 2026 (timely).
• Transaction type/code: Purchase (P) — issuance of Exchange Shares under a Debt Exchange Agreement.
• Shares acquired and price: 388,532 shares; reported at $0.37/share; footnote exchange rate $0.3732/share (FMV).
• Consideration: $145,000 of debt owed by the company to the CEO was converted into shares.
• Shares owned after transaction: Not disclosed in the provided filing.
• Notable footnote: F1 — shares issued pursuant to a dated Debt Exchange Agreement between Mr. Siokas and the company.
• No 10b5-1 plan, tax-withholding or late-filing flags noted in the provided data.

Context
This was a debt-for-equity conversion rather than a cash open-market purchase: the company reduced a $145k liability to its CEO in exchange for newly issued shares. Such transactions increase insider equity without requiring the insider to spend cash; the dollar value here is modest. Retail investors may view insider purchases (including debt conversions) as alignment of interests, but this single, relatively small issuance should be considered alongside other insider activity and the company’s overall financial condition.